June 2, 2025

NRG Oncology Broadcast archives are accessible from our website at any time. Please bookmark this link for your convenience.

NRG Oncology Summer Meeting Registration is OPEN

More information can be found on our

Summer Meeting

webpage. 

NRG SUMMER MEETING

NRG Oncology Summer Meeting Registration is Open!

Join us in Washington DC for the NRG2025 Summer Meeting. The meeting will be held in-person at the Marriott Marquis, July 24-26, 2025, with select virtual sessions being held July 16-25, 2025. Register soon to avoid the late registration fee!

More information | Agenda | Register

Real ID Reminder - Travel Requirements

As of May 7, 2025, a REAL ID or another acceptable form of identification, like a passport, is required to board domestic flights. Please visit the DHS website for more information on this travel requirement.

NRG Summer 2025 Symposium - Antibody Drug Conjugates: Selection, Sequencing and Future Strategies in Solid Tumors

Join us on in Washington, DC on Thursday, July 24, 2025 from 8am-12pm ET. The session will also be available virtually. This symposium offers a valuable opportunity to explore the expanding role of ADCs in the treatment of ovarian, cervical, endometrial, breast, lung, genitourinary and gastrointestinal cancers, highlighting their impact on clinical practice and patient outcomes. Program Chair - Kathleen Moore, MD and Co-Chair - Paolo Tarantino, MD

More information | Register

NRG Advanced Practice Provider (APP) Symposium

Calling all APPs! We are pleased to announce our NRG Oncology Advanced Practice Providers (APP) Symposium to be held during the NRG2025 Summer Meeting in Washington, DC on Friday, July 25, 2025, 8:15-9:45am ET. The session will also be available virtually. The goals for the session will be to identify the different roles that APPs can serve in NCI-sponsored research and elevate their involvement in clinical research at practice sites. The session chairs are Deb Bruner, Kathleen Castro, Christa Braun-Inglis, and Melyssa Foust.

More information | Register

ACTIVATION

CANCER CONTROL

NRG-CC013: Reopen to Accrual and Amendment 1, dated June 02, 2025, posted on CTSU.

OTHER PROTOCOL NOTICES

1. ALL DISEASE SITES

NRG-GY022: Reminder: Actively Recruiting MALE Patients only Read More

2. BIOSPECIMEN BANKS

Printing Biospecimen Transmittal PDFs from Rave

Please note an effort is underway to clarify how to obtain a Biospecimen Transmittal PDF for submission to the NRG Oncology Biospecimen Bank. Read More

3. BRAIN

NRG-BN013: The Spanish-translated consent form for Amendment 1 and CIRB approval of the form are available on the CTSU website.

4. BREAST

NRG-BR008/HERO: Reminder that this trial is open and actively enrolling patients. Helpful materials pertaining to BR008 can be found on the NRG Oncology website under Clinical Trials/NRG-BR008/Documents & Materials or on the CTSU website.

5. GYNECOLOGIC

NRG-GY025: Reminder! Enrollment for this study is still open to all NCTN sites.

NRG-GY026: Now accruing patients of all stages and all histologic subtypes of endometrial cancer.

NRG-GY031: Please note, there is an error in the section 4.2 table and the Biospecimen Collection and Submission Manual. The Part I PK collection is to be done on Cycle 1, Day 1, and Cycle 1, Day 8. This will be updated with the next amendment.

6. HEAD & NECK

NRG-HN008

Reminder: please update treatment and AE data weekly. This is a Phase I trial and timely data submission is very important.

7. VTOC TRAINING

The VTOC Webinar Training Series schedule and registration is available for NRG Oncology Research Associates working on NRG-BN014, NRG-BR009, NRG-CC003, NRG-CC005, NRG-CC011, NRG-CC013, NRG-CC014, NRG-HN001, NRG-HN002, and NRG-HN014. Space is limited so register now and reserve your seat. The next webinar training is scheduled for June 11, 2025.

Drug Safety updates have been issued for the following studies:

*The current version of the Investigator Brochure Documents for Division of Cancer Treatment and Diagnosis (DCTD), National Cancer Institute (NCI)-sponsored trials are available for access via the Cancer Therapy Evaluation Program (CTEP) Agent Inventory Management System (AURORA) application. Log-in using your Identity and Access Management (IAM) or ID.me credentials and provide the requested information to access the document.

Every site principal investigator is responsible for reviewing this document. The Investigator Brochure is for use by the site principal investigator and any study personnel under his/her supervision who need to know the contents for the conduct of a clinical trial, including Institutional Review Board(s) or Independent Ethics Committee(s).

1. REGISTER TODAY: The NRG-GU012 (SAMURAI) Webinar

The NRG-GU012 “SAMURAI” Study Principal Investigators will be hosting a webinar to discuss the trial and accept any questions regarding the study from sites. This webinar will be held on Friday, June 13 from 12-1pm ET / 9-10am PT. NRG-GU012 is a Phase II study of stereotactic ablative radiation therapy (SABR) for patients with unresected renal cell carcinoma receiving immunotherapy.

Register here.

3. RFA for the NRG Patient Advocate Committee – PCOR and Ovarian Cancer Representatives

Applications DUE June 9, 2025 - Read more and how to apply

4. REMINDER! GYN Cancer Committee is Requesting Proposals in Advance of the NRG Winter Meeting

Submission Deadline: June 20, 2025

Submit completed proposals to GYNconcepts@nrgoncology.org. See details here.

5. Healthcare Access Committee (HCA) Symposium Recording Now Available

The recording of the NRG Healthcare Access Committee Annual Symposium, Conquering the Geospatial Divide Challenging Rural Research & Cancer Care Delivery: Real world discussions with rural providers, trialists, and patient caregivers, (April 30, 2025) is now posted under the NRG Healthcare Access Committee page on the NRG Oncology website (login required).

6. NRG Member Information Form

We are excited to introduce the NRG Member Information Data Collection Initiative that will allow us to create a comprehensive member database, enabling us to better understand and serve our members. Your information will be kept secure and confidential, ensuring that your privacy is always protected. All members are encouraged to complete the form or indicate that they wish to opt out of this data collection initiative. 

Scan the QR code below or click this link to access the form. 

Questions? Read more here

REMINDER: Any manuscript or abstract resulting from research conducted under the auspices of our NCI grant awards must be processed through the NRG Publications Office before being submitted to the journal or association.

Please reach out to NRG-Publications@NRGOncology.org as a first step to ensure all requirements are met.

Please note the following upcoming meetings and abstract submission deadlines

UPCOMING MEETINGS:

American Brachytherapy Society (ABS); Jun 18-21, 2025; Nashville, TN

American Society of Clinical Oncology (ASCO); May 30-Jun 3, 2025; Chicago, IL

Canadian Association of Radiation Oncology (CARO); Sep 10-13, 2025; Calgary, AB

ESMO Gynaecological Cancers; Jun 19-21, 2025; Vienna, Austria

International Society for Quality-of-Life Research (ISOQOL); Oct 22-25, 2025; Milwaukee, WI

Radiological Society of North America (RSNA); Nov 30-Dec 4, 2025; Chicago, IL

Western Association of Gynecologic Oncologists (WAGO); Jun 18-21, 2025; Colorado Springs, CO

UPCOMING ABSTRACT SUBMISSION DEADLINES:

AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; Sep 18-21, 2025; Baltimore, MD; Due to publications committee Jun 10, 2025; Submission deadline Jun 24, 2025, 1:00 pm ET

AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics; Oct 22-26, 2025; Boston, MA; Due to publications committee Jul 7, 2025; Submission deadline Jul 21, 2025, 1:00 pm ET; LBA and Clinical Trials Sep 10, 2025, 1:00 pm ET

American Society for Radiation Oncology (ASTRO); Sep 28-Oct 1, 2025; San Francisco, CA; LBA Jul 10, 2025, 11:59 pm PT

European Society for Medical Oncology (ESMO); Oct 17-21, 2025; Berlin, Germany; LBA Sep 9, 2025, 21:00 CET (placeholder required)

ESMO Gastrointestinal Cancers; Jul 2-5, 2025; Barcelona, Spain; LBA Jun 5, 2025, 21:00 CET (placeholder required)

International Gynecologic Cancer Society (IGCS); Nov 5-7, 2025; Cape Town, South Africa; LBA Sep 29, 2025 (placeholder required)

San Antonio Breast Cancer Symposium (SABCS); Dec 9-12, 2025; San Antonio, TX; Due to publications committee Jun 25, 2025; Submission deadline Jul 9, 2025, 6:00 pm CT; LBA Sep 30, 2025, 11:59 pm CT

Society for Immunotherapy of Cancer (SITC); Nov 5-9, 2025; National Harbor, MD; Due to publications committee Jun 12, 2025; Submission deadline Jun 26, 2025

Society for Neuro-Oncology (SNO); Nov 19-23, 2025; Honolulu, HI; Submission deadline Jun 6, 2025, 11:59 pm ET; LBA Sep 2, 2025, 5:00 pm ET

Society of Urologic Oncology (SUO); Dec 2-5, 2025; Dallas, TX; Due to publications committee Jul 22, 2025; Submission deadline Aug 5, 2025